cbdMD, Inc.

YCBD NYSE CIK: 0001644903

Company Information

Industry Perfumes, Cosmetics & Other Toilet Preparations
SIC Code 2844
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NC
Business Address 8845 RED OAK BOULEVARD, CHARLOTTE, NC, 28217
Mailing Address 8845 RED OAK BOULEVARD, CHARLOTTE, NC, 28217
Phone 704-445-3060
Fiscal Year End 0930
EIN 473414576

Financial Overview

FY2026

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement February 12, 2026 View on SEC
S-1 IPO registration statement January 22, 2026 View on SEC
10-K/A Annual report amendment January 20, 2026 View on SEC
8-K Current report of material events January 14, 2026 View on SEC
S-1 IPO registration statement January 5, 2026 View on SEC
424B4 Prospectus for IPO or offering December 23, 2025 View on SEC
S-1/A IPO registration amendment December 22, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment December 19, 2025 View on SEC
4 Insider stock transaction report December 19, 2025 View on SEC
10-K Annual financial report December 19, 2025 View on SEC

Annual Reports

10-K December 19, 2025
  • cbdMD operates in the growing, but competitive, CBD product market.
  • The annual report did not provide specific financial figures for sales, profit, cash reserves, or debt, making it impossible to assess financial health or growth.
View Analysis

Material Events

8-K Financial Distress December 8, 2025
High Impact
  • cbdMD, Inc. has officially regained good standing with the NYSE American stock exchange.
  • The company successfully addressed and fixed issues that had put its stock at risk of being delisted.
View Analysis

Insider Trading

STRONG SELL 1 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2844)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.